In the second part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of supply chain operations & ...

The majority of Teva's business lies in generic and off-patent branded drugs which faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...

Steve Collis’ three decades of experience at a major drug distributor could prove helpful for Elevance as it continues to ...

In the first part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of supply chain operations & ...

Modern weight loss medications represent a breakthrough, but they are most effective when combined with the right lifestyle strategies. Here's what that looks like.

FOX 13's Kimberly Kuizon reports. Donald Trump announces deal to end Republican revolt Jennifer Garner and John Miller Are "More Connected Than Ever" After Rare Appearance There’s a new ‘bonus ...

Drugs are almost invariably cheap to manufacture and distribute. It would be rare that a drug would sell for more than $30 per prescription without a patent or some other form of protection from ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Cencora (COR), which belongs to the Zacks ...

Florida’s importation program hasn’t brought in a single Canadian drug. It’s not cost-effective and it could be dangerous.

FDA should judge drugs on what they do in real life, not just in companies’ clinical trials by Aaron Kheriaty, opinion contributor - 07/08/25 7:00 AM ET ...

Pindolol, a beta-blocker for high blood pressure, is typically covered by Medicare Part D or MAPD plans.

Biotechnology Scientists Genetically Engineer Tobacco Plants to Pump Out a Popular Cancer Drug Newly discovered genes could make powerful drug, Taxol, cheaper and more sustainable to produce.